Abstract:The 1-, 2-, 3-and 5-year patient survival rates were 100 %, 98,7%, 98,7% and 88,4% in diabetics. History of cardiovascular complications and higher peritonitis rate were not associated with death in the diabetic patients (p= 0,584 ; p=0,297). Conclusions: Despite the adverse outcomes and the high mortality rate, PD remains a viable form of long-term kidney replacement therapy for diabetic patients with ESRD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.